Home » Mera Pharmaceuticals Announces Broker Agreement
Mera Pharmaceuticals Announces Broker Agreement
Mera Pharmaceuticals, a leader in the commercial cultivation of microalgae, announced that it has received its initial order from a well-established, international broker that Mera has engaged to sell its products to the nutraceutical industry. The order is for Mera's AstaFactor brand astaxanthin, a powerful antioxidant and anti-inflammatory. Mera's chief executive, Dan Beharry, considers the development as a positive step for the Hawaii-based company.
mysan.de (http://www.mysan.de/article97568.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May